Topic: Government Payers

  • Impact of President’s Budget and Point of Sale Rebate Proposal for Part D: 10 Year Projection

    Impact of President’s Budget and Point of Sale Rebate Proposal for Part D: 10 Year Projection

  • List Price, Net Price, and the Rebate Caught in the Middle

  • DPL Responds to HHS RFI for IPI Drug Pricing Model (Nov. 30, 2018)

  • Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

    Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

  • Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?

    Does the 6% in Medicare Part B Drug Reimbursement Affect Prescribing?

  • Association of Rebates in Part D with Patient OOP and Federal Spending

    Association of Rebates in Part D with Patient OOP and Federal Spending

  • The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C

  • Part B Pilot Congressional Concerns

    Part B Pilot Congressional Concerns

  • Part B Payment for Medicare Drugs

    Part B Payment for Medicare Drugs

  • Overspending Driven by Oversized Single Dose Vials of Cancer Drugs

    Overspending Driven by Oversized Single Dose Vials of Cancer Drugs